AI-generated summary
The authors randomized 60 hemodialysis patients with restless legs syndrome to 940 nm near-infrared light applied to leg and foot acupoints or to sham treatment, over 12 sessions. They report that RLS severity scores were lower in the light group at the end of treatment, but the difference was not clinically significant after treatment stopped. The study was single-blind and was limited to a single trial.
- Participants
- 60
- Who or what was studied
- Patients undergoing hemodialysis with restless legs syndrome
- Wavelengths
- 940 nm
- Limits stated in the abstract
- The abstract reports a single-blind design with a relatively small sample of 60 patients and does not describe long-term follow-up.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on clinmedres.org.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 940 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Near-infrared, Randomized controlled trial, Control group, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.